Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders (Q38019745)

27 August 2017

title

Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders (English)

1 reference

27 August 2017

1

Ana Cristina Andreazza

1 reference

27 August 2017

publication date

1 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

2503-2512

1 reference

Prevalence and treatment of mental disorders, 1990 to 2003

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Clinical impact of late diagnose of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Manic symptoms and quality of life in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Drug research: a plan for mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Characterization of the human primary visual cortex and cerebellum proteomes using shotgun mass spectrometry-data-independent analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

DNA damage in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidatively modified proteins in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Actin S-glutathionylation: evidence against a thiol-disulphide exchange mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Redox sensing by proteins: oxidative modifications on cysteines and the consequent events

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Histone carbonylation occurs in proliferating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Mitochondrial Ca2+ sequestration and precipitation revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Proton pumping by NADH:ubiquinone oxidoreductase. A redox driven conformational change mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

The pathophysiology of mitochondrial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

How mitochondria produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Biochemistry of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative stress: from basic research to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Cell transformation by the superoxide-generating oxidase Mox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative stress, thiol redox signaling methods in epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

A simple method to systematically study oxidatively modified proteins in biological samples and its applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

FRET microscopy in the living cell: different approaches, strengths and weaknesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

The BRET technology and its application to screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Imaging proteins in vivo using fluorescence lifetime microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Investigation of membrane protein interactions using the split-ubiquitin membrane yeast two-hybrid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

G protein-coupled receptor heteromers as new targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

5-Hydroxymethylcytosine: a new kid on the epigenetic block?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

An epigenetic perspective on the free radical theory of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative DNA damage and global DNA hypomethylation are related to folate deficiency in chromate manufacturing workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Molecular evidence for mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Possible role of nitric oxide and adrenomedullin in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative stress in schizophrenia: An integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Electron microscopy of oligodendroglia in severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Altered glutathione redox state in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Gene regulation and DNA damage in the ageing human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Replicative aging, telomeres, and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative stress in developmental brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Proteomic technologies for biomarker studies in psychiatry: advances and needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: a possible mechanism for antipsychotic-induced metabolic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Epigenetic alterations of the dopaminergic system in major psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Current status and future prospects for epigenetic psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Biomarkers in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Oxidative stress markers in bipolar disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Proteomic profile of reversible protein oxidation using PROP, purification of reversibly oxidized proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

THE LACTIC ACID AND GLUTATHIONE CONTENT OF THE BLOOD OF SCHIZOPHRENIC PATIENTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

The Rho1 GTPase acts together with a vacuolar glutathione S-conjugate transporter to protect yeast cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25118C

21 January 2018

Identifiers

DOI

10.1039/C2MB25118C

1 reference

27 August 2017

1 reference